TR201909405T4 - Suda çözünebi̇li̇r vi̇norelbi̇n tuzunun stabi̇l farmasöti̇k bi̇leşi̇mi̇ - Google Patents

Suda çözünebi̇li̇r vi̇norelbi̇n tuzunun stabi̇l farmasöti̇k bi̇leşi̇mi̇ Download PDF

Info

Publication number
TR201909405T4
TR201909405T4 TR2019/09405T TR201909405T TR201909405T4 TR 201909405 T4 TR201909405 T4 TR 201909405T4 TR 2019/09405 T TR2019/09405 T TR 2019/09405T TR 201909405 T TR201909405 T TR 201909405T TR 201909405 T4 TR201909405 T4 TR 201909405T4
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
water
stable pharmaceutical
salt
vinorelbine
Prior art date
Application number
TR2019/09405T
Other languages
English (en)
Inventor
Paillard Bruno
Avan Jean-Loui̇s
Bougaret Joël
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TR201909405T4 publication Critical patent/TR201909405T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Bir suda çözünebilir vinorelbin tuzu içeren bir stabil farmasötik bileşim ve en az bir seyreltici ve bir yağlayıcı olup, karakterize edici özelliği, oral tatbik için amaçlanan katı bir formda görülmesidir. Suda çözünebilir vinorelbin tuzu, avantajlı olarak vinorelbin ditartrattır. Farmasötik bileşim avantajlı olarak bir jelatin kapsül ya da tablet olarak görünür.
TR2019/09405T 2007-07-11 2008-07-09 Suda çözünebi̇li̇r vi̇norelbi̇n tuzunun stabi̇l farmasöti̇k bi̇leşi̇mi̇ TR201909405T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0756425A FR2918567B1 (fr) 2007-07-11 2007-07-11 Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.

Publications (1)

Publication Number Publication Date
TR201909405T4 true TR201909405T4 (tr) 2019-07-22

Family

ID=38846787

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/09405T TR201909405T4 (tr) 2007-07-11 2008-07-09 Suda çözünebi̇li̇r vi̇norelbi̇n tuzunun stabi̇l farmasöti̇k bi̇leşi̇mi̇

Country Status (22)

Country Link
US (1) US20100196465A1 (tr)
EP (1) EP2175855B1 (tr)
JP (1) JP5774308B2 (tr)
KR (1) KR20100045439A (tr)
CN (1) CN101730534A (tr)
AR (1) AR067498A1 (tr)
AU (1) AU2008274224A1 (tr)
BR (1) BRPI0814224A2 (tr)
CA (1) CA2695040A1 (tr)
DK (1) DK2175855T3 (tr)
ES (1) ES2733113T3 (tr)
FR (1) FR2918567B1 (tr)
HU (1) HUE044165T2 (tr)
MA (1) MA31541B1 (tr)
NZ (1) NZ583039A (tr)
PL (1) PL2175855T3 (tr)
RU (1) RU2476208C2 (tr)
TN (1) TN2010000012A1 (tr)
TR (1) TR201909405T4 (tr)
TW (1) TW200914017A (tr)
WO (1) WO2009007389A1 (tr)
ZA (1) ZA201000337B (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105267179B (zh) * 2014-07-08 2020-04-03 东曜药业有限公司 包含水溶性长春瑞滨盐的稳定的固体药物组合物及其制备方法
EP3426665A1 (en) * 2016-03-09 2019-01-16 Synbias Pharma AG Vinorelbine monotartrate and its pharmaceutical use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879541A (en) * 1970-03-03 1975-04-22 Bayer Ag Antihyperglycemic methods and compositions
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
DE69918977T2 (de) * 1998-05-15 2005-07-28 Warner-Lambert Co. Llc Aminosäure-stabilisierte gabapentin und pregabalin zubereitungen und verfahren zu ihrer herstellung
US6242003B1 (en) * 2000-04-13 2001-06-05 Novartis Ag Organic compounds
CZ20002567A3 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
CA2434169C (en) * 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
JP4234017B2 (ja) * 2002-04-26 2009-03-04 エフ．ホフマン−ラ ロシュ アーゲー リパーゼ阻害薬及びグルコマンナンを含む医薬組成物
JP2003321349A (ja) * 2002-05-08 2003-11-11 Capsugel Japan Inc イカスミ色素含有インクによる硬質カプセルへの印刷
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
AU2003240808B2 (en) * 2002-05-31 2008-05-08 R. P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
US20030138430A1 (en) * 2002-09-20 2003-07-24 Stimmel Julie Beth Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US9061015B2 (en) * 2004-12-30 2015-06-23 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it

Also Published As

Publication number Publication date
JP2010533140A (ja) 2010-10-21
DK2175855T3 (da) 2019-07-01
FR2918567B1 (fr) 2012-08-03
JP5774308B2 (ja) 2015-09-09
BRPI0814224A2 (pt) 2015-01-06
FR2918567A1 (fr) 2009-01-16
WO2009007389A1 (en) 2009-01-15
RU2476208C2 (ru) 2013-02-27
NZ583039A (en) 2012-06-29
US20100196465A1 (en) 2010-08-05
EP2175855A1 (en) 2010-04-21
KR20100045439A (ko) 2010-05-03
EP2175855B1 (en) 2019-04-10
MA31541B1 (fr) 2010-07-01
PL2175855T3 (pl) 2019-10-31
ZA201000337B (en) 2010-09-29
CA2695040A1 (en) 2009-01-15
AR067498A1 (es) 2009-10-14
AU2008274224A1 (en) 2009-01-15
HUE044165T2 (hu) 2019-10-28
RU2010103935A (ru) 2011-08-20
TW200914017A (en) 2009-04-01
CN101730534A (zh) 2010-06-09
TN2010000012A1 (en) 2011-09-26
ES2733113T3 (es) 2019-11-27

Similar Documents

Publication Publication Date Title
MX2010004222A (es) Formulaciones solidas de compuestos cristalinos.
MA32876B1 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
TR200604349A2 (tr) Aripiprazol içeren farmasötik bileşimler
SG194756A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
MX2009004439A (es) Composicion de ibuprofeno.
NO20065763L (no) Manufacturing og quick release pharaceutical compositions of water insoluble drugs and pharaceutical compositions obtained by the progcess og the invention
TR201010683A1 (tr) Vildagliptin formülasyonları.
MX340571B (es) Capsula que se desintegra especificamente en el intestino grueso.
TR200908237A2 (tr) Kalsiyum ve D vitamini içeren farmasötik bileşimler.
TR201909405T4 (tr) Suda çözünebi̇li̇r vi̇norelbi̇n tuzunun stabi̇l farmasöti̇k bi̇leşi̇mi̇
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
MX2010001092A (es) Composicion farmaceutica liquida estable basada en trazodona.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
TN2010000013A1 (en) Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії
TR201722039A2 (tr) Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
TR201005241A1 (tr) Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
TR201721824A2 (tr) Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon
GR1004331B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
PL400338A1 (pl) Stala doustna postac dawkowania zawierajaca L-jablczan sunitynibu
WO2011128631A3 (en) Vegetarian oral pharmaceutical and nutraceutical compositions
TW200833375A (en) Pharmaceutical compositions
IN2015MU00907A (tr)